CC
SGRY icon

Cannell & Co’s Surgery Partners SGRY Stock Holding History

Cannell & Co’s Portfolio SGRY Stock Details SGRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$266K Sell
8,300
-76,670
-90% -$2.22M 0.01% 240
2023
Q3 		$2.49M Buy
+84,970
New +$3.06M 0.09% 120
2023
Q2 		– Sell
-162,210
Closed -$5.59M – 272
2023
Q1 		$5.59M Sell
162,210
-363,495
-69% -$11.8M 0.2% 101
2022
Q4 		$14.6M Sell
525,705
-366,450
-41% -$9.7M 0.53% 64
2022
Q3 		$20.9M Buy
892,155
+530,910
+147% +$17M 0.8% 49
2022
Q2 		$10.4M Buy
361,245
+135,270
+60% +$5.91M 0.38% 78
2022
Q1 		$12.4M Buy
225,975
+46,475
+26% +$2.3M 0.37% 77
2021
Q4 		$9.59M Buy
179,500
+171,450
+2,130% +$7.95M 0.27% 93
2021
Q3 		$341K Buy
8,050
+3,000
+59% +$153K 0.01% 249
2021
Q2 		$336K Hold
5,050
– – 0.01% 245
2021
Q1 		$224K Sell
5,050
-14,150
-74% -$525K 0.01% 262
2020
Q4 		$557K Sell
19,200
-1,800
-9% -$44.8K 0.02% 200
2020
Q3 		$460K Sell
21,000
-31,600
-60% -$562K 0.02% 191
2020
Q2 		$609K Buy
+52,600
New +$577K 0.02% 164

Other funds holding SGRY

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Cannell & Co's SGRY Position: Q4 2023 in Review

Cannell & Co reduced its Surgery Partners (SGRY) stake by 90% in Q4 2023, selling an estimated $2.22M and leaving 8,300 shares worth $266K. The position accounts for 0.01% of the portfolio, ranked #240.

Cannell & Co first reported a position in SGRY in Q2 2020 and has held it in 14 quarters since. The position peaked at $20.9M in Q3 2022. 174 funds tracked by Wall St. Rank hold SGRY as of Q4 2023.

  • Cannell & Co held 8,300 shares of Surgery Partners worth $266K as of Q4 2023.
  • Cannell & Co sold 76,670 Surgery Partners shares in Q4 2023, an estimated $2.22M.
  • Surgery Partners made up 0.01% of Cannell & Co's portfolio in Q4 2023, its #240 holding.
  • Cannell & Co first reported a position in Surgery Partners in Q2 2020 and has held it in 14 quarters since.
  • Cannell & Co's Surgery Partners position peaked at $20.9M in Q3 2022.
  • 174 funds tracked by Wall St. Rank held Surgery Partners as of Q4 2023.

Based on Cannell & Co's 13F filing for Q4 2023, filed 5 Feb 2024.